Publications

5891 Results

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial [PMID20697084; PMC2954132]

Authors
EA Perez;MM Reinholz;DW Hillman;KS Tenner;MJ Schroeder;NE Davidson;S Martino;G Sledge;LN Harris;J Gralow;AC Dueck;RP Kettering;J Ingle;WL Lingle;PA Kaufman;DW Visscher;RB Jenkins
Journal / Conference
Journal of Clinical Oncology 28(28):4307-4315
Year
2010
Research Committee(s)
Breast
Study Number(s)
N9831

Preliminary evaluation of factors associated with premature trial closure and feasibillity of accrual benchmarks in phase III oncology trials

Authors
AT Schroen;GR Petroni;H Wang;R Gray;XF Wang;W Cronin;DJ Sargent;J Benedetti;DL Wickerham;B Djulbegovic;CL Slingluff
Journal / Conference
Clinical Trials 7(4):312-321
Year
2010
Research Committee(s)
Multiple sites
PMID
PMID10595245

Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial PMID20952028

Authors
DK Price;CH Chau;C Till;P Goodman;CE Baum;SB Ockers;BC English;L Minasian;H Parnes;A Hsing;JK Reichardt;CM Tangen;A Kristal;IM Thompson;WD Figg
Journal / Conference
Journal of Urology 184(6):2297-2302
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma PMID20724727; PMC2935478

Authors
IM Thompson;DP Ankerst;CM Tangen
Journal / Conference
Journal of the National Cancer Institute 102(17):1299-1301
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a Children's Oncology Group and Southwest Oncology Group Study

Authors
P. Ho;K. Kopecky;T. Alonzo;R. Gerbing;K. Miller;J. Kuhn;R. Ries;S. Raimondi;B. Hirsch;V. Oehler;C Hurwitz;J. Franklin;A. Gamis;S. Petersdorf;J. Anderson;J. Godwin;G. Reaman;C. Willman;I. Bernstein;J. Radich;F. Appelbaum;D. Stirewalt;S. Meshinchi
Journal / Conference
Blood 2010 116:Abstract 2737; American Society of Hematology Annual Meeting; poster
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031, SWOG-9500

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10 [PMID19922915; PMC2799232]

Authors
CA Butts;K Ding;L Seymour;P Twumasi-Ankrah;B Graham;D Gandara;DH Johnson;KA Kesler;M Green;M Vincent;Y Cormier;G Goss;B Findlay;DH Johnson;MS Tsao;FA Shepherd
Journal / Conference
Journal of Clinical Oncology 289(1):29-34
Year
2010
Research Committee(s)
Lung
Study Number(s)
JBR10

Survival and years of life lost in different age cohorts of patients with multiple myeloma

Authors
H Ludwig;V Bolejack;J Crowley;J Blade;J Miguel;RA Kyle;SV Rajkumar;K Shimizu;I Turesson;J Westin;P Sonneveld;M Cavo;M Boccadoro;A Palumbo;P Tosi;JL Harousseau;M Attal;B Barlogie;AK Stewart;B Durie
Journal / Conference
Journal of Clinical Oncology 28(9):1599-1605
Year
2010
Research Committee(s)
Myeloma
PMID
PMID20177027

Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic olilgodendrogliomas: radiation therapy oncology group trial 9402 (RTOG; NCCTG; SWOG; NCIC CTG; ECOG) [PMID19783377; PMC2878934]

Authors
M Wang;JG Cairncross;E Shaw;R Jenkins;B Scheithauer;D Brachman;J Buckner;K Fink;L Souhami;N Laperriere;M Mehta;W Curran
Journal / Conference
International Journal of Radiation Oncology, Biology and Physics 77(3):662-669
Year
2010
Research Committee(s)
Brain
Study Number(s)
SWOG-9402

Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization. PMID: 19526354

Authors
JA Sparano;GN Hortobagyi;J Gralow;EA Perez;RL Comis
Journal / Conference
Breast Cancer Research and Treatment 119(3):511-527
Year
2010
Research Committee(s)
Breast

Outcome of adolescents and young adults (AYAs) with non-M3 acute myeloid leukemia (AML) treated on Children's Oncology Group (COG) trials compared to Cancer and Leukemia Group B (CALGB) and Southwest Oncology Group (SWOG) trials

Authors
A Franklin;T Alonzo;RB Gerbing;K Donohue;M Othus;J Horan;E Estey;RA Larson;WG Woods
Journal / Conference
Blood 116:Abstract 183; poster
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9500